Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.40 | $-0.42 | 4.76 % |
Jun 2024 | 2024-08-13 | $-0.33 | $-0.47 | 29.8 % |
Mar 2024 | 2024-05-09 | $-0.47 | $-0.49 | 4.08 % |
Dec 2023 | 2024-02-26 | $-0.45 | $-0.52 | 13.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $3.07M | $1.33M | 132.0 % |
Jun 2024 | 2024-08-13 | $6.77M | $1.41M | 380.3 % |
Mar 2024 | 2024-05-09 | $1.93M | $1.11M | 73.4 % |
Dec 2023 | 2024-02-26 | $1.68M | $1.59M | 5.41 % |
Fate Therapeutics (FATE) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.40, which beat the estimate of $-0.42.
The Actual Revenue was $3.1M, which beat the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.